Pharmacist News and Research

RSS

There are many tasks that a pharmacist is responsible for each day. Pharmacists are some of the most accessible members of the healthcare team, as individuals can seek their advice quickly and easily, even without an appointment.

Women should not be alarmed by study linking HRT to Alzheimer’s disease

Doctors are encouraging women not to be alarmed by a study linking the use of hormone replacement therapy (HRT) with a slightly increased risk of Alzheimer’s disease.

7 Mar 2019

Study finds drug interactions in ER's are common but could be prevented

In a recent Rutgers study, 38 percent of patients discharged from the emergency department had at least one drug interaction resulting from a newly prescribed medicine.

26 Feb 2019

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past two years, the result of its actions to streamline a cumbersome process and combat anti-competitive practices.

7 Feb 2019

Pharmacy in future: Transformational change is essential in all practice settings

Medications improve health and saves lives, but they are not risk-free. The modern pharmacist is largely responsible for helping patients navigate an increasingly complex and costly health care system, particularly with respect to medications.

5 Feb 2019

Telephone follow-up by pharmacists benefits patients after hospital discharge

A new British Journal of Clinical Pharmacology study illustrates the benefits of having clinical pharmacists follow up, by telephone, with patients at risk of having medication-related issues after hospital discharge. The aim is to help patients manage their medications effectively.

24 Jan 2019

UIC researchers receive $1.7 million NCI grant to study Southeast Asian fruit

For generations, traditional healers in Southeast Asia have used the mangosteen fruit to treat skin infections, wounds, dysentery and urinary tract infections.

18 Jan 2019

Scientists design two AI algorithms to improve early detection of cognitive impairment

Researchers of the Pharmacy and Mathematics departments of the CEU UCH university in Valencia have collaborated in the design of two artificial intelligence algorithms that improve the screening of positive cases in the early detection of cognitive impairment in chemists.

17 Jan 2019

Pharmacists could significantly reduce ED crowdedness

Incorporating pharmacists with an expanded scope into the community or hospital emergency departments (ED) could significantly reduce ED crowdedness, according to a new study.

10 Jan 2019

Barbershop-based medical intervention can successfully lower blood pressure, new data shows

New 12-month data from the Smidt Heart Institute at Cedars-Sinai backs up an earlier study proving that a pharmacist-led, barbershop-based medical intervention can successfully lower blood pressure in high-risk African-American men. The follow-up research was published today in the journal Circulation.

18 Dec 2018

FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall

The U.S. Food and Drug Administration today released a warning letter issued to Zhejiang Huahai Pharmaceutical Co. Ltd. (ZHP), in Linhai, Taizhou Zhejiang China, the manufacturer of the active pharmaceutical ingredient (API) found in valsartan that is the subject of an ongoing FDA investigation into probable cancer-causing impurities in certain commonly prescribed heart medicines.

12 Dec 2018

IDSA guidelines: Review by ID physician improves outcomes for outpatient parenteral antimicrobial therapy

Before patients receive intravenous antimicrobial infusion therapy outside of the hospital - whether at home, a doctor's office or a skilled nursing facility - an infectious diseases specialist should review the order to ensure the most appropriate treatment, suggest updated guidelines released by the Infectious Diseases Society of America.

14 Nov 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

Republicans’ drive to tighten immigration overlooks need for doctors

Dr. Alluri Raju, a native of India, vividly remembers how his ethnicity prompted concern and discrimination in the southwest Georgia town of Richland. Doctors there hesitated to grant the family practitioner and general surgeon privileges to the local hospital when he arrived in 1981.

30 Oct 2018

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.

22 Oct 2018

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.

22 Oct 2018

Study: Sarcoma patients poorly informed about risk of interactions with anti-cancer drugs

Sarcoma patients show great openness to the use of complementary alternative medicines (CAMs) for supportive care, but they are poorly informed about safety issues and risk of interactions with anti-cancer drugs, a study to be presented at ESMO 2018 reported.

10 Oct 2018

Sink traps are unexpected source of drug-resistant bacteria in ICU, study reveals

During a nationwide outbreak of healthcare-associated infections of an antibiotic-resistant bacteria, an Israeli hospital traced repeated infections of patients in its intensive care unit to an unexpected source--sink traps, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

5 Oct 2018

FDA takes new steps to address opioid crisis by approving Opioid Analgesic Risk Evaluation and Mitigation Strategy

Today, the U.S. Food and Drug Administration took new steps as part of its broader efforts to address the opioid crisis by approving the final Opioid Analgesic Risk Evaluation and Mitigation Strategy.

19 Sep 2018

Most parents aren't able to recognize meningitis until it's too late

New research commissioned by GSK has shown that the majority of parents incorrectly think that a rash or stiff neck are the first signs of meningitis.

14 Sep 2018